Form 4 for HCWB HCW Biologics Inc.
Accepted 2023-06-09 00:00:00 ET · period of report 2023-06-09 · accession 0001209191-23-036040 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-06-09 | 2023-06-09 | HCWB | Byam Rebecca | CFO | P - Purchase | $2.06 | +20.0K | 543.9K | +4% | +$41.2K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-09 | P | A | 20,000 | $2.06 | 543,946 | D | — | — | (F1) The range of prices for the shares of Common Stock is from $1.99 to $2.18. The reporting person undertakes that she will provide, upon request by the staff of the U.S. Securities and Exchange Commission, full information regarding the number of securities purchased at each separate price. |